Novo Nordisk has unveiled a new direct-to-patient online pharmacy which will offer Wegovy at less than half its standard price.

U.S. stocks climbed near their all-time high after oil prices eased further on hopes that Israel’s war with Iran will not damage the global flow of crude.

Insurers are cutting coverage, citing costs. But there’s seldom any discussion of the return on investment from these drugs ...

Adding to the pressure is that CVS Health has retained coverage of Zepbound's arch rival Wegovy (semaglutide), sold by Novo Nordisk, after negotiating a price cut with the company, along with Novo ...

Novo Nordisk cut off Hims & Hers Health from selling lower-priced Wegovy on Monday morning, but its explanation for the abrupt decision—which set Hims shares down more than 30%—doesn’t add up. Novo ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

A key inflation gauge moved higher in May in the latest sign that prices remain stubbornly elevated while Americans cut back on their spending.

Bernstein SocGen Group reiterated an Outperform rating and $1,100.00 price target on Eli Lilly (NYSE: LLY) stock Monday, citing continued strong performance of its weight loss medication Zepbound.

Abbott Laboratories is a dividend growth machine that's known for consistency. AbbVie's dividend has more than quadrupled ...

Oil prices leap 7% and US stocks slump more than 1% on worries about the crude market The S&P 500 sank 1.1% Friday and wiped out what had been a modest gain for the week.

Ikea shoppers will see price cuts of up to 50% at many of the company's restaurants globally, as the Swedish retail giant aims to attract cost-conscious consumers.